Starling Oncology, Inc.
STLNW- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $163.5K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Starling Oncology, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −1 vs. Q1 2023
- Shares held
- 4.29M
- +103.1K (+2.5%) vs. Q1 2023
- Total value
- $132.4K
- −$80.6K (−37.8%) vs. Q1 2023
- New holders
- 0
- 5 more added
- Sold out
- 1
- 1 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STLNW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $163.5K |
| Q1 2026 | 11 | $172.4K |
| Q4 2025 | 11 | $465.1K |
| Q3 2025 | 12 | $469.0K |
| Q2 2025 | 11 | $195.4K |
| Q1 2025 | 11 | $94.9K |
| Q4 2024 | 14 | $19.0K |
| Q3 2024 | 15 | $52.0K |
| Q2 2024 | 18 | $108.0K |
| Q1 2024 | 15 | $827.5K |
| Q4 2023 | 16 | $806.9K |
| Q3 2023 | 15 | $406.9K |
| Q2 2023 | 15 | $132.4K |
| Q1 2023 | 17 | $232.3K |
| Q4 2022 | 14 | $346.4K |
| Q3 2022 | 14 | $1.78M |
| Q2 2022 | 13 | $1.61M |
| Q1 2022 | 14 | $3.90M |
| Q4 2021 | 22 | $2.56M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Starling Oncology, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| LMR Partners LLP | 1,568,564 | $43.8K | 0.00% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 1,250,000 | $34.9K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 510,115 | $14.2K | 0.00% | +30,242+6.3% | Added |
| Davidson Kempner Capital Management LP | 318,710 | $8.86K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $7.32K | 0.00% | – | – |
| Man Group plc | 94,740 | $4.26K | 0.00% | – | – |
| Healthcare of Ontario Pension Plan Trust Fund | 87,500 | $3.94K | 0.00% | 00.0% | Unchanged |
| Difesa Capital Management, LP | 82,749 | $3.72K | 0.01% | −33,226−28.6% | Reduced |
| Cowen and Company, LLC | 120,600 | $3.36K | 0.00% | +300+0.2% | Added |
| Jefferies Financial Group Inc. | 95,000 | $2.65K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 83,542 | $2.33K | 0.00% | +200+0.2% | Added |
| Citadel Advisors LLC | 28,010 | $1.26K | 0.00% | +10,703+61.8% | Added |
| Alpine Global Management, LLC | 25,024 | $1.13K | 0.00% | 00.0% | Unchanged |
| Tenor Capital Management Co., L.P. | 25,000 | $698 | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 393 | $11 | 0.00% | +200+103.6% | Added |
| Bank of America Corp | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Davidson Kempner Partners | – | – | – | – | Not filed |